vs
Side-by-side financial comparison of APPFOLIO INC (APPF) and Nutex Health, Inc. (NUTX). Click either name above to swap in a different company.
APPFOLIO INC is the larger business by last-quarter revenue ($262.2M vs $151.7M, roughly 1.7× Nutex Health, Inc.). APPFOLIO INC runs the higher net margin — 16.2% vs 7.8%, a 8.4% gap on every dollar of revenue. On growth, APPFOLIO INC posted the faster year-over-year revenue change (20.4% vs -41.1%). Over the past eight quarters, Nutex Health, Inc.'s revenue compounded faster (50.0% CAGR vs 15.3%).
AppFolio, Inc. is an American company founded in 2006 that offers software-as-a-service (SaaS) applications and services to the real estate industry.
Nutex Health Inc. is an American for-profit health care company and operator of healthcare facilities headquartered in Houston, Texas.
APPF vs NUTX — Head-to-Head
Income Statement — Q1 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $262.2M | $151.7M |
| Net Profit | $42.4M | $11.8M |
| Gross Margin | — | 30.4% |
| Operating Margin | 19.4% | 20.4% |
| Net Margin | 16.2% | 7.8% |
| Revenue YoY | 20.4% | -41.1% |
| Net Profit YoY | 35.2% | -80.8% |
| EPS (diluted) | $1.18 | $2.34 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $262.2M | — | ||
| Q4 25 | $248.2M | $151.7M | ||
| Q3 25 | $249.4M | $267.8M | ||
| Q2 25 | $235.6M | $244.0M | ||
| Q1 25 | $217.7M | $211.8M | ||
| Q4 24 | $203.7M | $257.6M | ||
| Q3 24 | $205.7M | $78.8M | ||
| Q2 24 | $197.4M | $76.1M |
| Q1 26 | $42.4M | — | ||
| Q4 25 | $39.9M | $11.8M | ||
| Q3 25 | $33.6M | $55.4M | ||
| Q2 25 | $36.0M | $-17.7M | ||
| Q1 25 | $31.4M | $21.2M | ||
| Q4 24 | $102.7M | $61.6M | ||
| Q3 24 | $33.0M | $-8.8M | ||
| Q2 24 | $29.7M | $-364.0K |
| Q1 26 | — | — | ||
| Q4 25 | — | 30.4% | ||
| Q3 25 | — | 57.8% | ||
| Q2 25 | — | 51.2% | ||
| Q1 25 | — | 55.9% | ||
| Q4 24 | — | 55.0% | ||
| Q3 24 | — | 27.8% | ||
| Q2 24 | — | 29.7% |
| Q1 26 | 19.4% | — | ||
| Q4 25 | 17.6% | 20.4% | ||
| Q3 25 | 14.1% | 48.7% | ||
| Q2 25 | 17.2% | 13.8% | ||
| Q1 25 | 15.5% | 38.1% | ||
| Q4 24 | 11.3% | 44.4% | ||
| Q3 24 | 20.7% | 12.3% | ||
| Q2 24 | 18.3% | 7.0% |
| Q1 26 | 16.2% | — | ||
| Q4 25 | 16.1% | 7.8% | ||
| Q3 25 | 13.5% | 20.7% | ||
| Q2 25 | 15.3% | -7.3% | ||
| Q1 25 | 14.4% | 10.0% | ||
| Q4 24 | 50.4% | 23.9% | ||
| Q3 24 | 16.0% | -11.2% | ||
| Q2 24 | 15.0% | -0.5% |
| Q1 26 | $1.18 | — | ||
| Q4 25 | $1.10 | $2.34 | ||
| Q3 25 | $0.93 | $7.76 | ||
| Q2 25 | $0.99 | $-2.95 | ||
| Q1 25 | $0.86 | $3.33 | ||
| Q4 24 | $2.79 | $11.56 | ||
| Q3 24 | $0.90 | $-1.72 | ||
| Q2 24 | $0.81 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $147.4M | $185.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $470.2M | $329.4M |
| Total Assets | $580.6M | $918.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $147.4M | — | ||
| Q4 25 | $107.0M | $185.6M | ||
| Q3 25 | $76.1M | $166.0M | ||
| Q2 25 | $73.5M | $96.7M | ||
| Q1 25 | $56.9M | $84.7M | ||
| Q4 24 | $42.5M | $40.6M | ||
| Q3 24 | $62.4M | $46.9M | ||
| Q2 24 | $59.6M | $40.8M |
| Q1 26 | $470.2M | — | ||
| Q4 25 | $542.6M | $329.4M | ||
| Q3 25 | $498.9M | $317.2M | ||
| Q2 25 | $455.6M | $235.3M | ||
| Q1 25 | $462.1M | $176.9M | ||
| Q4 24 | $519.3M | $132.4M | ||
| Q3 24 | $412.8M | $60.4M | ||
| Q2 24 | $371.4M | $62.7M |
| Q1 26 | $580.6M | — | ||
| Q4 25 | $689.0M | $918.5M | ||
| Q3 25 | $640.5M | $964.5M | ||
| Q2 25 | $567.4M | $841.0M | ||
| Q1 25 | $564.7M | $761.9M | ||
| Q4 24 | $626.7M | $655.3M | ||
| Q3 24 | $523.3M | $438.5M | ||
| Q2 24 | $479.3M | $422.4M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $34.3M | $70.4M |
| Free Cash FlowOCF − Capex | — | $69.0M |
| FCF MarginFCF / Revenue | — | 45.5% |
| Capex IntensityCapex / Revenue | — | 0.9% |
| Cash ConversionOCF / Net Profit | 0.81× | 5.95× |
| TTM Free Cash FlowTrailing 4 quarters | — | $245.6M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $34.3M | — | ||
| Q4 25 | $65.0M | $70.4M | ||
| Q3 25 | $86.0M | $99.5M | ||
| Q2 25 | $52.6M | $27.3M | ||
| Q1 25 | $38.5M | $51.0M | ||
| Q4 24 | $36.6M | $54.0K | ||
| Q3 24 | $57.8M | $6.8M | ||
| Q2 24 | $50.9M | $13.3M |
| Q1 26 | — | — | ||
| Q4 25 | $63.7M | $69.0M | ||
| Q3 25 | $84.7M | $99.2M | ||
| Q2 25 | $52.4M | $26.5M | ||
| Q1 25 | $38.2M | $50.9M | ||
| Q4 24 | $36.4M | $-341.0K | ||
| Q3 24 | $57.4M | $6.2M | ||
| Q2 24 | $50.8M | $12.7M |
| Q1 26 | — | — | ||
| Q4 25 | 25.7% | 45.5% | ||
| Q3 25 | 34.0% | 37.0% | ||
| Q2 25 | 22.2% | 10.9% | ||
| Q1 25 | 17.6% | 24.0% | ||
| Q4 24 | 17.9% | -0.1% | ||
| Q3 24 | 27.9% | 7.8% | ||
| Q2 24 | 25.8% | 16.7% |
| Q1 26 | — | — | ||
| Q4 25 | 0.5% | 0.9% | ||
| Q3 25 | 0.5% | 0.1% | ||
| Q2 25 | 0.1% | 0.3% | ||
| Q1 25 | 0.1% | 0.0% | ||
| Q4 24 | 0.1% | 0.2% | ||
| Q3 24 | 0.2% | 0.8% | ||
| Q2 24 | 0.0% | 0.7% |
| Q1 26 | 0.81× | — | ||
| Q4 25 | 1.63× | 5.95× | ||
| Q3 25 | 2.56× | 1.80× | ||
| Q2 25 | 1.46× | — | ||
| Q1 25 | 1.23× | 2.40× | ||
| Q4 24 | 0.36× | 0.00× | ||
| Q3 24 | 1.75× | — | ||
| Q2 24 | 1.71× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
APPF
| Value Added Services | $201.4M | 77% |
| Subscription Services | $58.2M | 22% |
NUTX
| Hospital Division | $143.7M | 95% |
| Population Health Management Division | $8.0M | 5% |
